[1] |
KLEMEN N D, FEINGOLD P L, HASHIMOTO B,et al. Mortality risk associated with venous thromboembolism:a systematic review and Bayesian meta-analysis[J]. Lancet Haematol, 2020, 7(8):e583-593. DOI: 10.1016/S2352-3026(20)30211-8.
|
[2] |
LUTSEY P L, ZAKAI N A. Epidemiology and prevention of venous thromboembolism[J]. Nat Rev Cardiol, 2023, 20(4):248-262. DOI: 10.1038/s41569-022-00787-6.
|
[3] |
|
[4] |
KUCZMIK W, WYSOKINSKI W E, HESLEY G K,et al. Calf vein thrombosis comparison of outcomes for axial and muscular venous thrombosis[J]. Thromb Haemost, 2021, 121(2):216-223. DOI: 10.1055/s-0040-1715646.
|
[5] |
WANG C J, SHI C, GUO R,et al. Comparison of clinical outcomes among patients with isolated axial vs muscular calf vein thrombosis:a systematic review and meta-analysis[J]. J Vasc Surg Venous Lymphat Disord, 2024, 12(2):101727. DOI: 10.1016/j.jvsv.2023.101727.
|
[6] |
DE MAESENEER M G, BOCHANEN N, VAN ROOIJEN G,et al. Analysis of 1,338 patients with acute lower limb deep venous thrombosis(DVT)supports the inadequacy of the term "proximal DVT" [J]. Eur J Vasc Endovasc Surg, 2016, 51(3):415-420. DOI: 10.1016/j.ejvs.2015.11.001.
|
[7] |
|
[8] |
STEVENS S M, WOLLER S C, KREUZIGER L B,et al. Antithrombotic therapy for VTE disease:second update of the CHEST guideline and expert panel report[J]. Chest, 2021, 160(6):e545-608. DOI: 10.1016/j.chest.2021.07.055.
|
[9] |
SCHELLONG S, AGENO W, CASELLA I B,et al. Profile of patients with isolated distal deep vein thrombosis versus proximal deep vein thrombosis or pulmonary embolism:re-COVERY DVT/PE study[J]. Semin Thromb Hemost, 2022, 48(4):446-458. DOI: 10.1055/s-0041-1729169.
|
[10] |
RO A, KAGEYAMA N, MUKAI T. Pathophysiology of venous thromboembolism with respect to the anatomical features of the deep veins of lower limbs:a review[J]. Ann Vasc Dis, 2017, 10(2):99-106. DOI: 10.3400/avd.ra.17-00035.
|
[11] |
RO A, KAGEYAMA N, TANIFUJI T,et al. Pulmonary thromboembolism:overview and update from medicolegal aspects[J]. Leg Med, 2008, 10(2):57-71. DOI: 10.1016/j.legalmed.2007.09.003.
|
[12] |
|
[13] |
李晓强,张福先,王深明. 深静脉血栓形成的诊断和治疗指南(第三版)[J]. 中国血管外科杂志(电子版),2017,9(4):250-257.
|
[14] |
|
[15] |
SCHWARZ T, BUSCHMANN L, BEYER J,et al. Therapy of isolated calf muscle vein thrombosis:a randomized,controlled study[J]. J Vasc Surg,2010,52(5):1246-1250.
|
[16] |
SALES C M, HAQ F, BUSTAMI R,et al. Management of isolated soleal and gastrocnemius vein thrombosis[J]. J Vasc Surg, 2010, 52(5):1251-1254. DOI: 10.1016/j.jvs.2010.05.102.
|
[17] |
MERRIMAN E, CHUNILAL S, BRIGHTON T,et al. Two weeks of low molecular weight heparin for isolated symptomatic distal vein thrombosis(TWISTER study)[J]. Thromb Res, 2021, 207:33-39. DOI: 10.1016/j.thromres.2021.09.004.
|
[18] |
|
[19] |
|
[20] |
RIGHINI M, GALANAUD J P, GUENNEGUEZ H,et al. Anticoagulant therapy for symptomatic calf deep vein thrombosis(CACTUS):a randomised,double-blind,placebo-controlled trial[J]. Lancet Haematol, 2016, 3(12):e556-562. DOI: 10.1016/S2352-3026(16)30131-4.
|
[21] |
KRET M R, LIEM T K, MITCHELL E L,et al. Isolated calf muscular vein thrombosis is associated with pulmonary embolism and a high incidence of additional ipsilateral and contralateral deep venous thrombosis[J]. J Vasc Surg Venous Lymphat Disord, 2013, 1(1):33-38. DOI: 10.1016/j.jvsv.2012.04.001.
|
[22] |
|
[23] |
MASUDA E M, KISTNER R L, MUSIKASINTHORN C,et al. The controversy of managing calf vein thrombosis[J]. J Vasc Surg, 2012, 55(2):550-561. DOI: 10.1016/j.jvs.2011.05.092.
|
[24] |
GALANAUD J P, SEVESTRE M A, GENTY C,et al. Comparison of the clinical history of symptomatic isolated muscular calf vein thrombosis versus deep calf vein thrombosis[J]. J Vasc Surg,2010,52(4):932-938,938.e1-938.e2.
|
[25] |
SARTORI M, MIGLIACCIO L, FAVARETTO E,et al. Two years outcome of isolated distal deep vein thrombosis[J]. Thromb Res, 2014, 134(1):36-40. DOI: 10.1016/j.thromres.2014.03.033.
|
[26] |
LI A Y, WOULFE T, ROLFE-VYSON V,et al. Management and outcomes of axial isolated distal deep vein thrombosis at north shore hospital,New Zealand:a retrospective audit[J]. Intern Med J, 2015, 45(2):177-182. DOI: 10.1111/imj.12664.
|
[27] |
SINGH K, YAKOUB D, GIANGOLA P,et al. Early follow-up and treatment recommendations for isolated calf deep venous thrombosis[J]. J Vasc Surg,2012,55(1):136-140.
|
[28] |
SARTORI M, LESSIANI G, FAVARETTO E,et al. Ultrasound characteristics of calf deep vein thrombosis and residual vein obstruction after low molecular weight heparin treatment[J]. Eur J Vasc Endovasc Surg,2016,52(5):658-664.
|
[29] |
|
[30] |
刘宝坤,周栋,屈睿升,等. 急性下肢深静脉血栓的腔内治疗进展[J]. 临床放射学杂志,2022,41(3):571-574.
|
[31] |
GARCIA R, LABROPOULOS N, GASPARIS A P,et al. Present and future options for treatment of infrainguinal deep vein disease[J]. J Vasc Surg Venous Lymphat Disord, 2018, 6(5):664-671. DOI: 10.1016/j.jvsv.2018.01.010.
|
[32] |
BROHOLM R, BÆKGAARD N, HANSEN S,et al. Significance of partial or complete thrombosis of the common and deep femoral vein in patients with deep vein thrombosis[J]. Eur J Vasc Endovasc Surg, 2019, 58(4):570-575. DOI: 10.1016/j.ejvs.2019.06.016.
|
[33] |
|
[34] |
|
[35] |
KLEIN S J, GASPARIS A P, VIRVILIS D,et al. Prospective determination of candidates for thrombolysis in patients with acute proximal deep vein thrombosis[J]. J Vasc Surg, 2010, 51(4):908-912. DOI: 10.1016/j.jvs.2009.11.043.
|
[36] |
李梦婷,潘峰,李林杨炼,等. 急性髂股静脉血栓的介入治疗研究进展[J]. 临床放射学杂志,2024,43(3):467-471.
|
[37] |
LIU G, ZHAO Z, CUI C Y,et al. Endovascular management of extensive lower extremity acute deep vein thrombosis with AngioJet rheolytic thrombectomy plus catheter-directed thrombolysis from contralateral femoral access[J]. Phlebology, 2019, 34(4):257-265. DOI: 10.1177/0268355518790407.
|
[38] |
KEARON C, GU C S, JULIAN J A,et al. Pharmacomechanical catheter-directed thrombolysis in acute femoral-popliteal deep vein thrombosis:analysis from a stratified randomized trial[J]. Thromb Haemost,2019,119(4):633-644.
|
[39] |
MAGNUSON E A, CHINNAKONDEPALLI K, VILAIN K,et al. Cost-effectiveness of pharmacomechanical catheter-directed thrombolysis versus standard anticoagulation in patients with proximal deep vein thrombosis:results from the ATTRACT trial[J]. Circ Cardiovasc Qual Outcomes, 2019, 12(10):e005659. DOI: 10.1161/CIRCOUTCOMES.119.005659.
|
[40] |
LIN M Y, HSIEH J C F, HANIF M,et al. Evaluation of thrombolysis using tissue plasminogen activator in lower extremity deep venous thrombosis with concomitant femoral-popliteal venous segment involvement[J]. J Vasc Surg Venous Lymphat Disord, 2017, 5(5):613-620. DOI: 10.1016/j.jvsv.2017.04.018.
|
[41] |
DOUKETIS J D, CROWTHER M A, FOSTER G A,et al. Does the location of thrombosis determine the risk of disease recurrence in patients with proximal deep vein thrombosis?[J]. Am J Med, 2001, 110(7):515-519. DOI: 10.1016/s0002-9343(01)00661-1.
|
[42] |
COUTURAUD F, PERNOD G, PRESLES E,et al. Six months versus two years of oral anticoagulation after a first episode of unprovoked deep-vein thrombosis. The PADIS-DVT randomized clinical trial[J]. Haematologica, 2019, 104(7):1493-1501. DOI: 10.3324/haematol.2018.210971.
|
[43] |
AGNELLI G, PRANDONI P, SANTAMARIA M G,et al. Three months versus one year of oral anticoagulant therapy for idiopathic deep venous thrombosis. Warfarin Optimal Duration Italian Trial Investigators[J]. N Engl J Med, 2001, 345(3):165-169. DOI: 10.1056/NEJM200107193450302.
|
[44] |
|
[45] |
KAHN S R, COMEROTA A J, CUSHMAN M,et al. The postthrombotic syndrome:evidence-based prevention,diagnosis,and treatment strategies:a scientific statement from the American Heart Association[J]. Circulation, 2014, 130(18):1636-1661. DOI: 10.1161/CIR.0000000000000130.
|
[46] |
ENDEN T, HAIG Y, KLØW N E,et al. Long-term outcome after additional catheter-directed thrombolysis versus standard treatment for acute iliofemoral deep vein thrombosis(the CaVenT study):a randomised controlled trial[J]. Lancet, 2012, 379(9810):31-38. DOI: 10.1016/S0140-6736(11)61753-4.
|
[47] |
KAKKOS S K, GOHEL M, BAEKGAARD N,et al. Editor's choice - European society for vascular surgery(ESVS)2021 clinical practice guidelines on the management of venous thrombosis[J]. Eur J Vasc Endovasc Surg,2021,61(1):9-82.
|
[48] |
ABRAMOWITZ S, SHAIKH A, MOJIBIAN H,et al. Comparison of anticoagulation vs mechanical thrombectomy for the treatment of iliofemoral deep vein thrombosis[J]. J Vasc Surg Venous Lymphat Disord, 2024, 12(4):101825. DOI: 10.1016/j.jvsv.2024.101825.
|
[49] |
TSAI C J, LEE C Y. Comparative outcomes of catheter-directed thrombolysis plus rivaroxaban vs rivaroxaban alone in patients with acute iliofemoral deep vein thrombosis[J]. J Chin Med Assoc,2019,82(12):902-908.
|
[50] |
BRADBURY C, FLETCHER K, SUN Y Z,et al. A randomised controlled trial of extended anticoagulation treatment versus standard treatment for the prevention of recurrent venous thromboembolism(VTE)and post-thrombotic syndrome in patients being treated for a first episode of unprovoked VTE(the ExACT study)[J]. Br J Haematol, 2020, 188(6):962-975. DOI: 10.1111/bjh.16275.
|
[51] |
SCHULMAN S, LINDMARKER P, HOLMSTRÖM M,et al. Post-thrombotic syndrome,recurrence,and death 10 years after the first episode of venous thromboembolism treated with warfarin for 6 weeks or 6 months[J]. J Thromb Haemost,2006,4(4):734-742.
|
[52] |
GALANAUD J P, SEVESTRE M A, GENTY C,et al. Incidence and predictors of venous thromboembolism recurrence after a first isolated distal deep vein thrombosis[J]. J Thromb Haemost, 2014, 12(4):436-443. DOI: 10.1111/jth.12512.
|
[53] |
ASONITIS K, CHARVALOS E, LAMBERT C,et al. Experience of a 40-day(6 week)LMWH treatment for isolated distal deep vein thrombosis[J]. J Thromb Thrombolysis, 2020, 50(4):837-843. DOI: 10.1007/s11239-020-02089-5.
|
[54] |
FERRARA F, MELI F, AMATO C,et al. Optimal duration of treatment in surgical patients with calf venous thrombosis involving one or more veins[J]. Angiology,2006,57(4):418-423.
|
[55] |
HAIG Y, ENDEN T, GRØTTA O,et al. Post-thrombotic syndrome after catheter-directed thrombolysis for deep vein thrombosis(CaVenT):5-year follow-up results of an open-label,randomised controlled trial[J]. Lancet Haematol, 2016, 3(2):e64-71. DOI: 10.1016/S2352-3026(15)00248-3.
|
[56] |
张明照,卢冉,向军益,等. 经皮穿刺胫后静脉入路治疗急性混合型单侧下肢深静脉血栓形成的疗效[J]. 中华全科医学,2022,20(4):560-564.
|
[57] |
AGNELLI G, BULLER H R, COHEN A,et al. Oral apixaban for the treatment of acute venous thromboembolism[J]. N Engl J Med,2013,369(9):799-808.
|
[58] |
CASTELLUCCI L A, CAMERON C, GAL G L,et al. Clinical and safety outcomes associated with treatment of acute venous thromboembolism:a systematic review and meta-analysis[J]. JAMA,2014,312(11):1122-1135.
|
[59] |
INVESTIGATORS H V, BÜLLER H R, DÉCOUSUS H,et al. Edoxaban versus warfarin for the treatment of symptomatic venous thromboembolism[J]. N Engl J Med, 2013, 369(15):1406-1415. DOI: 10.1056/NEJMoa1306638.
|